Where does Incospharm Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Incospharm Corporation ranks #40,884 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Incospharm Corporation hold?

Incospharm Corporation holds 6 US utility patents granted between 2015 and 2020, spanning 8 technology areas.

What is Incospharm Corporation's Innovation Score?

Incospharm Corporation has an Innovation Score of 23.7 out of 100 (13th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Incospharm Corporation focus on?

Incospharm Corporation's top technology area is A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations) with 5 patents, ranking #224 of 1,001 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Incospharm Corporation's patent grant rate increasing or decreasing?

Incospharm Corporation's recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Incospharm Corporation's patents?

Incospharm Corporation's patents average 11.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Incospharm Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Incospharm Corporation

USPTO PatentsView assignee record - 6 granted patents across 8 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Incospharm ranks #40,884 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 8 technology areas.

#40,884
of 49,997 US assignees by volume: 13th percentile
by Innovation Score (23.7/100): 11.7
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40884 · Foreign Corporation #40,884 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #40,884/49,997
PHOTO-FINISH IMS Solution
CPC-NARROW A61Q · 8 areas
INNOV-THIN 23.7/100
CLAIMS-PAR 11.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: IMS Solution, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Incospharm’s 23.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (28%) Velocity 0.0 pts (0%) Breadth 10.0 pts (42%) Claim depth 7.0 pts (30%)

Qualcomm Incorporated · highest

85
Incospharm · this assignee

24
3D Lighting… · lowest

7

What this shows Incospharm's Innovation Score is 23.7/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Incospharm?

Each dot is one of Incospharm’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Incospharm’s own 11.7 claims/patent is at or below the 16.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Incospharm vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Incospharm's grants concentrate

Incospharm Corporation is a focused PatentsView assignee: 8 CPC subclasses with 83.3% of grants classified under A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2015. By volume, Incospharm sits between IMS Solution, LLC and Industrial & Environmental Concepts, Inc..

IMS Solution

6
IMV

6
Inceptio Hongkong

6
Incom

6
Indian Head Indus…

6
Indoor Reality

6
Indoor Robotics

6
Industrial & Envi…

6
Incospharm ◀

6

What this shows Incospharm holds 6 patents at rank #40,850, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Incospharm

By rank, the assignees closest to #40,850 in granted patent volume.

Leaders in A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations)

Other assignees with the most granted patents in Incospharm's primary technology class.

Incospharm's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 13th percentile higher than 13% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Incospharm Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2016	1	16.7%
2018	1	16.7%
2019	1	16.7%
2020	2	33.3%

Which technologies does Incospharm Corporation patent most?

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C07K - Peptides 3

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 2

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 2

C07D - Heterocyclic Compounds 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Incospharm Corporation's patent record in context - here's where to go next.

Incospharm Corporation's lead technology class is A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations), 83.3% of its portfolio - see every assignee active in that class. Explore A61Q
Ranked #40,884 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Incospharm Corporation against IMS Solution, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.